Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
A man aged 32 years who self-described as men who have sex with men (MSM) started on-demand pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir (FTC/TDF) based on reporting 30 partners within the last 24 weeks, not using condoms in 50% of sex acts, use of gamma-hydroxybutyric acid during sex and previous STI diagnoses (Smith score=37).1 Over 1 year, we conducted 3-monthly STI screening and HIV-RNA testing. He tested HIV-negative at months 0, 3, 6 and 9. At month 12, he reported missing a single PrEP dose 1 month earlier due to gamma-hydroxybutyric …
Handling editor Anna Maria Geretti
Contributors SN visited the individual and contributed to writing the article. ARR contributed to writing the article. EB, DC and AC contributed to the review of the article. NG visited the individual and contributed to the review of the article. MS performed HIV resistance tests and contributed to the review of the article.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.